S1B-509
N/A
Report date: 2025/06/19 20:00:08
NME
Base Information
Drug NameS1B-509
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesS1 Biopharma Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A